Pharmacokinetics of antimicrobial agents in organ function impairment. A review
- PMID: 2277757
- DOI: 10.1007/BF01970152
Pharmacokinetics of antimicrobial agents in organ function impairment. A review
Abstract
The pharmacokinetics of antimicrobial drugs in various types of organ function impairment are reviewed. The influence of renal function impairment on antimicrobial agents is well-known, although less is known about the accumulation of metabolites during renal failure. Fewer data are available on liver function impairment and more information is needed on highly metabolized agents. Pharmacokinetic studies in severely ill patients are urgently needed to investigate the influence of disease states on pharmacokinetics and to study the possibility of oral administration to seriously ill patients.
Similar articles
-
[The pharmacokinetics of fluoroquinolones in different diseases].Antibiot Khimioter. 1997;42(1):23-9. Antibiot Khimioter. 1997. PMID: 9221701 Review. Russian.
-
Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis.Pharm World Sci. 1998 Aug;20(4):149-60. doi: 10.1023/a:1008634911114. Pharm World Sci. 1998. PMID: 9762727 Review.
-
Effect of renal impairment on the pharmacokinetics of grepafloxacin.Clin Pharmacokinet. 1997;33 Suppl 1:32-8. doi: 10.2165/00003088-199700331-00007. Clin Pharmacokinet. 1997. PMID: 9433654
-
The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.Br J Clin Pharmacol. 2002;53 Suppl 1(Suppl 1):21S-30S. doi: 10.1046/j.0306-5251.2001.00029.x. Br J Clin Pharmacol. 2002. PMID: 11879256 Free PMC article. Clinical Trial.
-
The effects of degree of hepatic or renal impairment on the pharmacokinetics of exemestane in postmenopausal women.Cancer Chemother Pharmacol. 2004 Jun;53(6):475-81. doi: 10.1007/s00280-004-0774-5. Epub 2004 Mar 11. Cancer Chemother Pharmacol. 2004. PMID: 15014897